744241-09-6

Basic information

• Product Name: [1,1'-Biphenyl]-4-ol, 3'-[(1E)-2-[4-(2,4-dichlorophenyl)-1H-imidazol-2-yl]ethenyl]-
• CAS NO: 744241-09-6
• Molecular Formula: C23H16Cl2N2O
• Molecular Weight: 407.299
• Mol File: 744241-09-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: [1,1'-Biphenyl]-4-ol, 3'-[(1E)-2-[4-(2,4-dichlorophenyl)-1H-imidazol-2-yl]ethenyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: [1,1'-Biphenyl]-4-ol, 3'-[(1E)-2-[4-(2,4-dichlorophenyl)-1H-imidazol-2-yl]ethenyl]-(744241-09-6)
• EPA Substance Registry System: [1,1'-Biphenyl]-4-ol, 3'-[(1E)-2-[4-(2,4-dichlorophenyl)-1H-imidazol-2-yl]ethenyl]-(744241-09-6)

Safety Data

• Hazardous Substances Data: 744241-09-6(Hazardous Substances Data)

Upstream product

• 744240-37-7 2-[2-(3-bromo-phenyl)-(E)-vinyl]-4-(2,4-dichloro-phenyl)-1H-imidazole 
• 71597-85-8 (p-hydroxyphenyl)boronic acid 

Relevant articles and documents

Substituted azole derivatives, compositions, and methods of use

The present invention provides azole derivatives of Formula (I), methods of their preparation, pharmaceutical compositions comprising the compounds of Formula (I), and their use in treating human or animal disorders. The compounds of the invention can be useful as inhibitors of protein tyrosine phosphatases and thus can be useful for the management, treatment, control, or the adjunct treatment of diseases mediated by PTPase activity. Such diseases include Type I diabetes and Type II diabetes.